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Abstract Ganglioside GalL1C3GalNAcL1C4(NeuAcK2C3)
GalL1C4GlcL1C1’Cer (GM1)-binding peptides were obtained
from a phage-displayed pentadecapeptide library by an affinity
selection. The selection processes were in situ-monitored by a
quartz-crystal microbalance method, on which a ganglioside
GM1 monolayer was transferred. After five rounds of biopan-
ning, the DNA sequencing of 18 selected phages showed that only
three individual clones were selected. The peptide sequences of
the random region were found to be DFRRLPGAFWQLRQP,
GWWYKGRARPVSAVA and VWRLLAPPFSNRLLP. Bind-
ing constants of these phage clones to the GM1 monolayer were
1010 M31. Three synthetic pentadecapeptides inhibited the
binding of cholera toxin B subunit to the GM1 monolayer with
an IC50 of 24, 13 and 1.0 WM, respectively. These peptides will be
useful for searching functional roles of ganglioside GM1.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Carbohydrate-protein interaction is an important process in
cell-cell recognition [1]. Thus, it is expected that the peptides
which inhibit carbohydrate-protein interaction will have great
potential in the prevention and therapy of various diseases. A
phage display technique has been developed by Smith et al. to
discover target-speci¢c proteins (peptides) [2]. By using the
phage display technique, Deng et al. selected lipopolysaccha-
ride-binding antibody [3]. Yamamoto et al. selected protein
having a⁄nity with mucin from a cDNA library [4]. Ganglio-
sides were also known as receptors for virus [5] and toxin [6],
cell-cell adhesion molecules [7] and modulators of signal
transduction [8^10]. Recently, Taki et al. developed glyco-
sphingolipid mimicking peptides and observed their function
as inhibitor for tumor metastasis [11,12]. In this study, we
attempted to obtain amino acid sequences which recognize
the oligosaccharide of gangliosides. There are no reports
about glycolipid-binding peptides so far.
We carried out a⁄nity selection, so-called ‘biopanning’,
with monosialoganglioside galactose (Gal)L1C3N-acetylga-
lactosamineL1C4(N-acetylneuraminic acid (NeuAc)K2C3)
GalL1C4glucoseL1C1’ceramide (Cer) (GM1), known as a
receptor for cholera toxin B subunit (CTB) [13]. We have tried
to select GM1-binding peptides by using a GM1-adsorbed
solid support. Though we obtained 60 individual phage
clones, those phages showed no consensus peptide sequences
(unpublished results). These results are considered to be
caused by the various orientation of ganglioside. Accordingly,
we reconsidered the strategy of biopanning and tried to em-
ploy an ordered ganglioside monolayer. Ganglioside mono-
layers can be prepared at an air-water interface as shown in
Fig. 1. Glycolipid monolayers have been employed to inves-
tigate the recognition function of glycolipid with lectin [14,15]
and in£uenza virus [16,17]. Hydrophilic carbohydrate portions
of glycolipids at the monolayer are exposed to the water
phase. Therefore, phages in the water phase will interact
only with the carbohydrate portion, but not with the hydro-
phobic Cer. Such a monolayer is expected to be suitable for
the selection of peptides which recognize oligosaccharide of
gangliosides presented in biomembranes.
2. Materials and methods
2.1. Reagents
The pentadecamer (15-mer) random peptide library displayed on a
¢lamentous phage (fd phage) and Escherichia coli K91Kan were ob-
tained as previously described [18]. GM1 was obtained from Prof.
Kawanishi of the Ogata Institute. GM1 was dissolved in chloro-
form/methanol (2:1) and stored below 320‡C. Bovine serum albumin
(BSA) (fraction V), anti-fd bacteriophage (rabbit IgG), peroxidase-
conjugated anti-rabbit IgG and peroxidase-conjugated CTB were pur-
chased from Sigma (St. Louis, MO, USA).
2.2. Biopanning and in situ monitoring
Experimental procedures were shown in Fig. 1. A mixed solvent of
chloroform and methanol (2:1) containing GM1 was spread on Tris-
bu¡ered saline (TBS) (50 mM Tris-HCl, 150 mM NaCl, pH 7.5) in a
Te£on-coated trough (USI, Fukuoka, Japan). A quartz-crystal micro-
balance (QCM, 9 MHz) was attached horizontally to the GM1 mono-
layer at the surface pressure of 30 mN/m (0.67 nm2/molecule, 0.39 Wg/
cm2) [15]. The QCM was transferred to a plastic tube ¢lled with 1 ml
TBS. The phage library (3^74U1010 transducing units (TU), see Table
1) was added to the bu¡er. The frequency decrease of QCM (mass
increase) corresponding to the binding of phages to the GM1 mono-
layer was followed with time. After the incubation for 12^15 min at
20‡C, the QCM was picked up from the bu¡er and was washed three
times with 50 Wl TBS. The phages bound to the GM1 monolayer were
eluted for 15 min with 0.1 N Gly-HCl bu¡er (pH 2.2). The eluate was
neutralized with 1 M Tris-HCl bu¡er (pH 9.1) and treated with Cen-
tricon-30 (Amicon). The obtained phage clones were ampli¢ed by
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infecting them to host bacterial cells (E. coli K91Kan). Such a bio-
panning process was repeated ¢ve times. After ¢ve cycles of biopan-
ning, the selected phage clones were isolated and subjected to DNA
sequencing according to the literature [11,12].
2.3. Assay for GM1-phage interaction by an enzyme-linked
immunosorbent assay (ELISA)
The selected phage clones were ampli¢ed and puri¢ed by precipita-
tion with polyethylene glycol 6000 (nacalai tesque, Japan). Virion
concentrations were determined by measuring the absorbance at
260 nm. Plastic plates (13.5 mm diameter, cell desk, Sumitomo Bake-
lite, Japan) were attached horizontally to the GM1 monolayer. The
phage clones (10311^1038 M in 200 Wl TBS) were incubated for 30 min
at room temperature with the GM1 monolayer-transferred plastic
plates. The plates were washed three times with TBS and transferred
into a 24 well plate (Falcon). The plates were blocked with 1% BSA/
TBS for 2 h at room temperature. The phages bound to GM1 mono-
layers were detected by the secondary antibody method (primary anti-
body, anti-fd bacteriophage; secondary antibody, peroxidase-conju-
gated anti-rabbit IgG). Orthophenylenediamine was used as color
producing reagent and the color development was determined at
492 nm by a microplate reader (Multiskan MS, Labsystems, Ger-
many).
2.4. Binding inhibition assay
The GM1 monolayer-transferred plastic plates were blocked with
1% BSA/TBS for 4 h at room temperature or overnight at 4‡C, then
washed with TBS. Horseradish peroxidase-conjugated CTB (1:5000
dilution in 200 Wl TBS containing 0.5% BSA) and synthetic peptides
(1037^1033 M) were incubated with the GM1 plates overnight at 4‡C
in a 24 well plate. The amount of CTB bound to GM1 monolayers
was determined by developing substrates as described above.
3. Results
3.1. Selection of GM1-binding peptides from a phage-displayed
peptide library
The GM1 monolayer-transferred QCM was used to select
GM1-recognizable phage clones. Binding of phages to the
GM1 monolayer was monitored by frequency changes of
QCM, which were responsible for the amount of phages
bound to GM1 (Fig. 1). Frequency changes were saturated
within 15 min after the addition of phages at each round.
These results indicate that a⁄nity selection completed within
15 min and that the amount of phages having a⁄nity for
GM1 increased with every round (Fig. 2). The recovery and
enrichment of the phage library at each round of biopanning
were determined and are shown in Table 1. The values of
recovery and enrichment increased with proceeding of biopan-
ning. These results resembled the results of QCM. At the ¢fth
round, the values of recovery and enrichment were less than
those at the fourth round. This may be caused by the addition
of excess phage. The number of output at the ¢fth round was
more than that at the fourth round. Thus, the ¢fth round of
biopanning is considered to be successful. Sequence analysis
of 18 clones obtained at the ¢fth round indicated that
only three di¡erent clones having DFRRLPGAFWQLRQP
(13/18, 72%, phage 1), GWWYKGRARPVSAVA (4/18,
22%, phage 2) and VWRLLAPPFSNRLLP (1/18, 6%, phage
3) were selected. The sequences DFRRLPGAFWQLRQP and
Fig. 1. Experimental procedures of biopanning.
Table 1
Results of biopanning with the GM1 monolayer
Round (th) Input (U1010)a Output (U105)a Recoveryb (U1036) Enrichment (per round) Enrichment (total)
1 6.1 2.4 3.9 ^ 1
2 5.5 13 24 6.2 6.2
3 4.8 30 63 2.6 16
4 3.0 130 430 6.8 110
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VWRLLAPPFSNRLLP share a motif RxLPxxFxxxRxP (Ta-
ble 2).
3.2. A⁄nity of phage clones and synthetic peptides for GM1
monolayers
Binding a⁄nities of the three phage clones at the ¢fth
round for GM1 monolayers were analyzed by the ELISA
method (Fig. 3). The phage clones signi¢cantly bound to the
GM1 monolayer depending on the concentration of phage,
while the control clone (LGRAGQSYPSFARGL) hardly
bounded. The dissociation constants, Kd values, were deter-
mined to be 0.2 nM for phage 1, 0.5 nM for phage 2 and 0.2
nM for phage 3. The selected phage clones have a high a⁄nity
to the GM1 monolayer in the order of 10310 M. Since Kd
values for GM1-CTB-binding were reported to be 1038^
10312 M [19^22], the binding abilities of the selected phages
are found to be comparable to those of CTB.
The peptides, DFRRLPGAFWQLRQP (peptide 1),
GWWYKGRARPVSAVA (peptide 2) and VWRLLAP-
PFSNRLLP (peptide 3), were chemically synthesized and
binding a⁄nities of these peptides for GM1 were evaluated
by an inhibition assay. Fig. 4 shows the amount of CTB
bound to the GM1 monolayer in the presence of peptides.
These three peptides inhibited the binding of CTB to the
GM1 monolayer. The IC50 values of synthetic peptides were
determined to be 24, 13 and 1.0 WM for peptide 1, 2 and 3,
respectively. Peptide 3 showed the highest inhibition for
GM1-CTB-binding.
4. Discussion
In this study, we improved the method of biopanning to
obtain ganglioside-binding peptides. Gangliosides in cells are
localized in the plasma membrane [23]. Thus, it is important
to display gangliosides that like the cell membrane for the
selection of ganglioside-binding peptides. Our ¢rst attempts
at selecting peptides speci¢c to ganglioside (GM1) randomly
adsorbed on a polyvinylidene di£uoride membrane were un-
successful, because more than 60 clones obtained had no con-
sensus sequences and did not show signi¢cant binding to
GM1 (unpublished results). From these results, we experi-
enced the importance of orientation of the lipid molecules.
Thus, we employed ganglioside-containing monolayers for
biopanning. It is expected that the monolayer is a suitable
condition to obtain peptides which bind to the oligosaccharide
portion of a ganglioside.
In the present study, we employed a QCM method to mon-
itor the binding of a phage library to the GM1 monolayer. A
QCM system has been used to analyze the interaction of gly-
cosphingolipids with proteins [14,15] and virus [16,17]. Fig. 1
showed that QCM can also detect the binding of ¢lamentous
phages employed in this study. Frequency changes of QCM
showed that binding of the phage library to the GM1 mono-
Fig. 2. In situ monitoring of the biopanning process by the QCM
method. The arrow indicates the time at which the phage pool was
injected into the bu¡er solution.
Table 2
Deduced amino acid sequences of peptide displayed on the phage
after the ¢fth round of biopanning
Clone name Sequencea Frequencyb
Phage 1 DFRRLPGAFWQLRQP 13/18
Phage 2 GWWYKGRARPVSAVA 4/18
Phage 3 VWRLLAPPFSNRLLP 1/18
aAmino acid sequences deduced from the DNA sequence. Consen-
sus sequences are denoted by bold letters.
bFrequency is the number of sequences among the total phage
clones isolated.
Fig. 3. Binding assay of selected phage clones to the GM1 mono-
layer. Phage clones were incubated with the GM1 monolayer-trans-
ferred plastic plates in TBS at room temperature for 30 min. After
washing, bound phages were detected by a sandwich assay using an
anti-fd phage antibody and an anti-rabbit IgG-peroxidase conjugate
antibody. (a) Phage 1, (b) phage 2, (c) phage 3, (d) control phage
(displaying LGRAGQSYPSFARGL). Each plot is the mean of trip-
licate.
Fig. 4. Inhibition of synthetic peptides for CTB-binding to GM1
monolayers. (a) peptide 1, DFRRLPGAFWQLRQP; (b) peptide 2,
GWWYKGRARPVSAVA; (c) peptide 3, VWRLLAPPFSNRLLP;
(d) control peptide, AREYGTRFSLTGGYR. Each plot is the mean
of triplicate.
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layer was completed within 15 min and we could obtain the
timing to go to the next operation. Malmborg et al. reported
about direct monitoring of the panning process by surface
plasmon resonance [24]. The present result indicated that
QCM is also useful for detection of the panning process as
well as surface plasmon resonance.
Inhibition studies for CTB-GM1 interaction showed that a
synthetic peptide 3 has the highest activity, which is 24- and
13-fold higher than peptide 1 and peptide 2, respectively.
Then, binding amounts of the synthetic peptides to the
GM1 monolayers were estimated by the QCM method (27
MHz, 1 Hz = 0.31 ng/cm2). The maximum binding amount
of peptide 3 was 88 ng/cm2, while those of the other two
peptides were 17^27 ng/cm2 (data not shown). These results
suggest that the high inhibition activity of peptide 3 was
caused by the large binding amount of it to GM1.
Previous studies on the carbohydrate-protein interaction
suggest that certain amino acids play important roles on the
interaction with carbohydrate [25,26]. For example: (a) argi-
nine interacts with the carbonyl group of a sialic acid through
electrostatic interaction for coat protein of murine polyoma
virus [27], (b) phenylalanine interacts with the hydrophobic
face of a galactopyranose ring for Erythrina corallodendron
lectin [28] and (c) proline contributes to bending of peptide
[29]. A RxLPxxFxxxRxP motif found in peptide 1 and peptide
3 contains two arginine (R), two proline (P) and a phenyl-
alanine (F). Therefore, the RxLPxxFxxxRxP motif is expected
to recognize Gal and NeuAc. In fact, the selected three pep-
tide sequences bound to GM1 having Gal and NeuAc (Figs. 3
and 4). X-ray analyses for CTB-GM1 pentasaccharide com-
plex were carried out by Merrit et al. and Zang et al. [30,31]
and showed that several amino acids such as Glu-11, Tyr-12,
His-13, Glu-51, Gln-56, Gln-61, Trp-88, Asn-90 and Lys-91
are correlated with CTB-GM1 interaction. No homology was
observed between the GM1-binding site of CTB and the se-
lected three peptides. But ¢ve carbohydrate-associable amino
acids, Gln (Q), Tyr (Y), Asn (N), Trp (W) and Lys (K), were
observed in the sequences of peptides 1^3.
In conclusion, the biopanning with the ganglioside mono-
layer was successful in selecting ganglioside-binding peptides.
Ganglioside-peptide interaction is considered to depend on
the orientation of the ganglioside. The technique of a
phage-displayed peptide library combined with the lipid
monolayer will be a strong tool for searching peptides which
speci¢cally bind to glycolipids in a biological membrane. Fur-
thermore, the obtained peptides will be useful probes for in-
vestigating roles of glycolipids in the cell membrane.
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